اثربخشی درمان الودگی و نگهداری وودولیزومب در بیماران مبتلا به کولیت اولسراتیو، صرف نظر از پیشگیری از آنتاگونیست فاکتور نابارور تومور

Vedolizumab demonstrated significantly greater efficacy as induction and maintenance therapy for UC than placebo in patients naive to TNF antagonists and patients with TNF antagonist failure. There were numerically greater treatment differences at Week 6 among patients receiving vedolizumab who were naive to TNF antagonists than patients with TNF antagonist failure. ClinicalTrials.gov no: NCT00783718.